ArticleJournal of cellular and molecular medicine2023

Adenosine receptor A2b confers ovarian cancer survival and PARP inhibitor resistance through IL-6-STAT3 signalling.

Liqing Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.